| Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells Y Liang, R Xu, L Zhang, X Zhao Acta Pharmacologica Sinica 30 (12), 1659-1665, 2009 | 74 | 2009 |
| Berbamine derivatives: a novel class of compounds for anti-leukemia activity J Xie, T Ma, Y Gu, X Zhang, X Qiu, L Zhang, R Xu, Y Yu European journal of medicinal chemistry 44 (8), 3293-3298, 2009 | 69 | 2009 |
| A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors Y Xu, Q Yu, P Wang, Z Wu, L Zhang, S Wu, M Li, B Wu, H Li, H Zhuang, ... Advanced Science 9 (8), 2104344, 2022 | 27 | 2022 |
| Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade H Wang, X He, L Zhang, H Dong, F Huang, J Xian, M Li, W Chen, X Lu, ... Blood, The Journal of the American Society of Hematology 139 (26), 3752-3770, 2022 | 24 | 2022 |
| 4-Chlorbenzoyl berbamine, a novel derivative of the natural product berbamine, potently inhibits the growth of human myeloma cells by modulating the NF-κB and JNK signalling … Y Liang, X He, X Li, X Zhang, X Zhang, L Zhang, X Qiu, X Zhao, R Xu Cancer investigation 34 (10), 496-505, 2016 | 21 | 2016 |
| Homoharringtonine combined with the heat shock protein 90 inhibitor IPI504 in the treatment of FLT3-ITD acute myeloid leukemia Z Wu, H Zhuang, Q Yu, X Zhang, X Jiang, X Lu, Y Xu, L Yang, B Wu, A Ma, ... Translational Oncology 12 (6), 801-809, 2019 | 17 | 2019 |
| HDAC4 inhibition disrupts TET2 function in high-risk MDS and AML F Huang, J Sun, W Chen, X He, Y Zhu, H Dong, H Wang, Z Li, L Zhang, ... Aging (Albany NY) 12 (17), 16759, 2020 | 16 | 2020 |
| Role of SIRT1 in hematologic malignancies F Huang, J Sun, L Zhang, X He, Y Zhu, H Dong, H Wang, L Zhu, J Zou, ... Journal of Zhejiang University. Science. B 20 (5), 391, 2019 | 16 | 2019 |
| Activation of CaMKIIγ potentiates T-cell acute lymphoblastic leukemia leukemogenesis via phosphorylating FOXO3a X Jiang, Z Wu, X Lu, X Zhang, Q Yu, Y Gan, B Wu, Y Xu, W Zheng, ... Oncotarget 8 (43), 75050, 2017 | 9 | 2017 |
| Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia Q Yu, Y Xu, H Zhuang, Z Wu, L Zhang, J Li, L Yang, B Wu, P Wang, ... Experimental Cell Research 384 (2), 111653, 2019 | 8 | 2019 |
| Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells L Zhang, J Tong, X He, Y Liang, L Zhu, R Xu, X Zhao Annals of Hematology 97, 2353-2362, 2018 | 7 | 2018 |
| Identification of the UBA2-WTIP fusion gene in acute myeloid leukemia X Lu, H Zhuang, Q Yu, X Zhang, Z Wu, L Zhang, Y Xu, B Wu, L Yang, ... Experimental Cell Research 371 (2), 409-416, 2018 | 6 | 2018 |
| TET2 deficiency promotes MDS-associated leukemogenesis F Huang, J Sun, W Chen, L Zhang, X He, H Dong, Y Wu, H Wang, Z Li, ... Blood Cancer Journal 12 (10), 141, 2022 | 4 | 2022 |
| Phosphoproteomics profiling reveals a kinase network conferring acute myeloid leukaemia intrinsic chemoresistance and indicates HMGA1 phosphorylation as a potential influencer Y Zhu, X He, S Li, Y Gan, Z Li, H Wang, H Dong, L Zhang, SL Xue, Y Xu, ... Clinical and Translational Medicine 12 (3), 2022 | 3 | 2022 |
